Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.

Schobert I, Chapiro J, Pucar D, Saperstein L, Savic LJ.

PET Clin. 2019 Oct;14(4):437-445. doi: 10.1016/j.cpet.2019.06.008. Epub 2019 Aug 7. Review.

PMID:
31472741
2.

Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia.

Ayyagari R, Powell T, Staib L, Chapiro J, Schoenberger S, Devito R, Pollak J.

J Vasc Interv Radiol. 2019 Sep;30(9):1459-1470. doi: 10.1016/j.jvir.2019.05.033. Epub 2019 Jul 30.

PMID:
31375451
3.

Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.

van Breugel JMM, Geschwind JF, Mirpour S, Savic LJ, Zhang X, Duran R, Lin M, Miszczuk M, Liapi E, Chapiro J.

Theranostics. 2019 May 27;9(13):3674-3686. doi: 10.7150/thno.32943. eCollection 2019.

4.

Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.

Wang CJ, Hamm CA, Savic LJ, Ferrante M, Schobert I, Schlachter T, Lin M, Weinreb JC, Duncan JS, Chapiro J, Letzen B.

Eur Radiol. 2019 Jul;29(7):3348-3357. doi: 10.1007/s00330-019-06214-8. Epub 2019 May 15.

PMID:
31093705
5.

Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.

Hamm CA, Wang CJ, Savic LJ, Ferrante M, Schobert I, Schlachter T, Lin M, Duncan JS, Weinreb JC, Chapiro J, Letzen B.

Eur Radiol. 2019 Jul;29(7):3338-3347. doi: 10.1007/s00330-019-06205-9. Epub 2019 Apr 23.

PMID:
31016442
6.

Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Erinjeri JP, Fine GC, Adema GJ, Ahmed M, Chapiro J, den Brok M, Duran R, Hunt SJ, Johnson DT, Ricke J, Sze DY, Toskich BB, Wood BJ, Woodrum D, Goldberg SN.

Radiology. 2019 Jul;292(1):25-34. doi: 10.1148/radiol.2019182326. Epub 2019 Apr 23.

PMID:
31012818
7.

A 3D quantitative imaging biomarker in pre-treatment MRI predicts overall survival after stereotactic radiation therapy of patients with a singular brain metastasis.

Della Seta M, Collettini F, Chapiro J, Angelidis A, Engeling F, Hamm B, Kaul D.

Acta Radiol. 2019 Mar 6:284185119831692. doi: 10.1177/0284185119831692. [Epub ahead of print]

PMID:
30841703
8.

Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization.

Schobert I, Chapiro J, Nezami N, Hamm CA, Gebauer B, Lin M, Pollak J, Saperstein L, Schlachter T, Savic LJ.

J Nucl Med. 2019 Aug;60(8):1066-1072. doi: 10.2967/jnumed.118.219691. Epub 2019 Jan 17.

PMID:
30655331
9.

The Role of Artificial Intelligence in Interventional Oncology: A Primer.

Letzen B, Wang CJ, Chapiro J.

J Vasc Interv Radiol. 2019 Jan;30(1):38-41.e1. doi: 10.1016/j.jvir.2018.08.032. Epub 2018 Dec 7. Review. No abstract available.

PMID:
30528289
10.

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma.

Abajian A, Murali N, Savic LJ, Laage-Gaupp FM, Nezami N, Duncan JS, Schlachter T, Lin M, Geschwind JF, Chapiro J.

J Vis Exp. 2018 Oct 10;(140). doi: 10.3791/58382.

PMID:
30371657
11.

Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.

Fereydooni A, Letzen B, Ghani MA, Miszczuk MA, Huber S, Chapiro J, Schlachter T, Geschwind JF, Georgiades C.

J Vasc Interv Radiol. 2018 Dec;29(12):1646-1653.e5. doi: 10.1016/j.jvir.2018.08.010. Epub 2018 Oct 15.

PMID:
30337148
12.

Liver tissue classification in patients with hepatocellular carcinoma by fusing structured and rotationally invariant context representation.

Treilhard J, Smolka S, Staib L, Chapiro J, Lin M, Shakirin G, Duncan J.

Med Image Comput Comput Assist Interv. 2017 Sep;10435:81-88. doi: 10.1007/978-3-319-66179-7_10. Epub 2017 Sep 4.

13.

Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.

Abajian A, Murali N, Savic LJ, Laage-Gaupp FM, Nezami N, Duncan JS, Schlachter T, Lin M, Geschwind JF, Chapiro J.

J Vasc Interv Radiol. 2018 Jun;29(6):850-857.e1. doi: 10.1016/j.jvir.2018.01.769. Epub 2018 Mar 14.

14.

Clinical Experience with Real-Time 3-D Guidance Based on C-Arm-Acquired Cone-Beam CT (CBCT) in Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Placement.

Böning G, Lüdemann WM, Chapiro J, Jonczyk M, Hamm B, Günther RW, Gebauer B, Streitparth F.

Cardiovasc Intervent Radiol. 2018 Jul;41(7):1035-1042. doi: 10.1007/s00270-018-1877-4. Epub 2018 Mar 14.

PMID:
29541837
15.

Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?

Murali N, Laage-Gaupp FM, Chapiro J, Geschwind JF.

Radiology. 2018 Feb;286(2):405-408. doi: 10.1148/radiol.2017171779.

PMID:
29356646
16.

Characteristics of a New X-Ray Imaging System for Interventional Procedures: Improved Image Quality and Reduced Radiation Dose.

Schernthaner RE, Haroun RR, Nguyen S, Duran R, Sohn JH, Sahu S, Chapiro J, Zhao Y, Radaelli A, van der Bom IM, Mauti M, Hong K, Geschwind JH, Lin M.

Cardiovasc Intervent Radiol. 2018 Mar;41(3):502-508. doi: 10.1007/s00270-017-1821-z. Epub 2017 Oct 31.

17.

Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?

Adam LC, Murali N, Chapiro J, Geschwind JF.

Radiology. 2017 Nov;285(2):333-335. doi: 10.1148/radiol.2017171527.

18.

C-Arm Cone Beam CT for Intraprocedural Image Fusion and 3D Guidance in Portal Vein Embolization (PVE).

Lüdemann WM, Böning G, Chapiro J, Jonczyk M, Geisel D, Schnapauff D, Wieners G, Schmelzle M, Chopra S, Günther RW, Gebauer B, Streitparth F.

Cardiovasc Intervent Radiol. 2018 Mar;41(3):424-432. doi: 10.1007/s00270-017-1782-2. Epub 2017 Sep 5.

PMID:
28875339
19.

Diagnostic Accuracy of Split-Bolus Single-Phase Contrast-Enhanced Cone-Beam CT for the Detection of Liver Tumors before Transarterial Chemoembolization.

Jonczyk M, Chapiro J, Collettini F, Geisel D, Schnapauff D, Streitparth F, Schmidt T, Hamm B, Gebauer B, Wieners G.

J Vasc Interv Radiol. 2017 Oct;28(10):1378-1385. doi: 10.1016/j.jvir.2017.05.018. Epub 2017 Jul 23.

PMID:
28747271
20.

Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.

Do Minh D, Chapiro J, Gorodetski B, Huang Q, Liu C, Smolka S, Savic LJ, Wainstejn D, Lin M, Schlachter T, Gebauer B, Geschwind JF.

Eur Radiol. 2017 Dec;27(12):4995-5005. doi: 10.1007/s00330-017-4856-2. Epub 2017 Jul 4.

21.

The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.

Smolka S, Chapiro J, Manzano W, Treilhard J, Reiner E, Deng Y, Zhao Y, Hamm B, Duncan JS, Gebauer B, Lin M, Geschwind JF.

Clin Imaging. 2017 Nov - Dec;46:1-7. doi: 10.1016/j.clinimag.2017.05.007. Epub 2017 Jun 7.

22.

Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?

Savic LJ, Chapiro J, Geschwind JF.

Radiology. 2017 Jun;283(3):621-623. doi: 10.1148/radiol.2017170358.

PMID:
28514219
23.

Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.

Savic LJ, Chapiro J, Geschwind JH.

Hepatobiliary Surg Nutr. 2017 Feb;6(1):7-21. doi: 10.21037/hbsn.2016.11.02. Review.

24.

Intra-arterial therapies for liver cancer: assessing tumor response.

Stroehl YW, Letzen BS, van Breugel JM, Geschwind JF, Chapiro J.

Expert Rev Anticancer Ther. 2017 Feb;17(2):119-127. doi: 10.1080/14737140.2017.1273775. Epub 2016 Dec 27. Review.

PMID:
27983883
25.

Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma.

Geschwind JH, Chapiro J.

Gastroenterol Hepatol (N Y). 2016 Aug;12(8):504-506. No abstract available.

26.

Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.

Mu L, Chapiro J, Stringam J, Geschwind JF.

Cancer J. 2016 Nov/Dec;22(6):365-372. Review.

27.

From the Guest Editor: Interventional Oncology: The Fourth Pillar of Oncology.

Kim HS, Chapiro J, Geschwind JH.

Cancer J. 2016 Nov/Dec;22(6):363-364. No abstract available.

28.

Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.

Sohn JH, Duran R, Zhao Y, Fleckenstein F, Chapiro J, Sahu S, Schernthaner RE, Qian T, Lee H, Zhao L, Hamilton J, Frangakis C, Lin M, Salem R, Geschwind JF.

Clin Gastroenterol Hepatol. 2017 May;15(5):746-755.e4. doi: 10.1016/j.cgh.2016.10.036. Epub 2016 Nov 12.

29.

Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

Sahu S, Schernthaner R, Ardon R, Chapiro J, Zhao Y, Sohn JH, Fleckenstein F, Lin M, Geschwind JF, Duran R.

Radiology. 2017 Jun;283(3):883-894. doi: 10.1148/radiol.2016160838. Epub 2016 Nov 10.

30.

Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.

Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Marshall K, Lin M, Gebauer B, Chapiro J, Salem R, Geschwind JF.

Transl Oncol. 2016 Oct;9(5):377-383. doi: 10.1016/j.tranon.2016.07.005. Epub 2016 Sep 12.

31.

Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.

Zhao Y, Duran R, Chapiro J, Sohn JH, Sahu S, Fleckenstein F, Smolka S, Pawlik TM, Schernthaner R, Zhao L, Lee H, He S, Lin M, Geschwind JF.

J Gastrointest Surg. 2016 Dec;20(12):2002-2009. Epub 2016 Oct 6.

32.

Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Geschwind JF, Chapiro J.

Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7. No abstract available.

PMID:
27487101
33.

Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.

Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE, Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF.

Clin Cancer Res. 2017 Jan 15;23(2):536-548. doi: 10.1158/1078-0432.CCR-16-0725. Epub 2016 Jul 20.

34.

Response.

Chapiro J, Goldberg SN, Galun E, Geschwind JF.

Radiology. 2016 Apr;279(1):323. No abstract available.

PMID:
27437552
35.

Science to Practice: Systemic Implications of Ablative Tumor Therapies-Reality Uncovered and Myths Exposed?

Chapiro J, Geschwind JF.

Radiology. 2016 Aug;280(2):329-31. doi: 10.1148/radiol.2016160505. Review.

PMID:
27429140
36.

Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.

Schernthaner RE, Haroun RR, Duran R, Lee H, Sahu S, Sohn JH, Chapiro J, Zhao Y, Gorodetski B, Fleckenstein F, Smolka S, Radaelli A, van der Bom IM, Lin M, Geschwind JF.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1429-37. doi: 10.1007/s00270-016-1406-2. Epub 2016 Jul 5.

37.

Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.

Gorodetski B, Chapiro J, Schernthaner R, Duran R, Lin M, Lee H, Lenis D, Stuart EA, Nonyane BA, Pekurovsky V, Tamrazi A, Gebauer B, Schlachter T, Pawlik TM, Geschwind JF.

Eur Radiol. 2017 Feb;27(2):526-535. doi: 10.1007/s00330-016-4445-9. Epub 2016 Jun 8.

38.

Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.

Savic LJ, Chapiro J, Hamm B, Gebauer B, Collettini F.

Rofo. 2016 Aug;188(8):735-45. doi: 10.1055/s-0042-104203. Epub 2016 Apr 13. Review.

39.
40.

Automatic bone removal for 3D TACE planning with C-arm CBCT: Evaluation of technical feasibility.

Wang Z, Hansis E, Chen R, Duran R, Chapiro J, Sheu YR, Kobeiter H, Grass M, Geschwind JF, Lin M.

Minim Invasive Ther Allied Technol. 2016;25(3):162-70. doi: 10.3109/13645706.2015.1129970. Epub 2016 Feb 29.

41.

3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.

Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Zhao Y, Hamm B, Gebauer B, Lin M, Geschwind JF, Chapiro J.

Eur Radiol. 2016 Sep;26(9):3243-52. doi: 10.1007/s00330-015-4168-3. Epub 2016 Jan 13.

42.

Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.

Tacher V, Duran R, Lin M, Sohn JH, Sharma KV, Wang Z, Chapiro J, Gacchina Johnson C, Bhagat N, Dreher MR, Schäfer D, Woods DL, Lewis AL, Tang Y, Grass M, Wood BJ, Geschwind JF.

Radiology. 2016 Jun;279(3):741-53. doi: 10.1148/radiol.2015141624. Epub 2015 Dec 16.

43.
44.

Three-dimensional quantitative assessment of lesion response to MR-guided high-intensity focused ultrasound treatment of uterine fibroids.

Savic LJ, Lin MD, Duran R, Schernthaner RE, Hamm B, Geschwind JF, Hong K, Chapiro J.

Acad Radiol. 2015 Sep;22(9):1199-205. doi: 10.1016/j.acra.2015.05.008. Epub 2015 Jul 7.

45.

3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Schneider T, Chapiro J, Lin M, Geschwind JF, Kleinberg L, Rigamonti D, Jusué-Torres I, Marciscano AE, Yousem DM.

Eur Radiol. 2016 Mar;26(3):849-57. doi: 10.1007/s00330-015-3895-9. Epub 2015 Jul 3.

46.

Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.

Tacher V, Lin M, Duran R, Yarmohammadi H, Lee H, Chapiro J, Chao M, Wang Z, Frangakis C, Sohn JH, Maltenfort MG, Pawlik T, Geschwind JF.

Radiology. 2016 Jan;278(1):275-84. doi: 10.1148/radiol.2015142951. Epub 2015 Jul 1.

47.

Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

Wang Z, Chen R, Duran R, Zhao Y, Yenokyan G, Chapiro J, Schernthaner R, Radaelli A, Lin M, Geschwind JF.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1548-56. doi: 10.1007/s00270-015-1129-9. Epub 2015 May 23.

48.

Feasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization.

Schernthaner RE, Chapiro J, Sahu S, Withagen P, Duran R, Sohn JH, Radaelli A, van der Bom IM, Geschwind JF, Lin M.

Radiology. 2015 Dec;277(3):833-41. doi: 10.1148/radiol.2015142821. Epub 2015 May 20.

49.

Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.

Chockalingam A, Duran R, Sohn JH, Schernthaner R, Chapiro J, Lee H, Sahu S, Nguyen S, Geschwind JF, Lin M.

Eur Radiol. 2016 Jan;26(1):103-13. doi: 10.1007/s00330-015-3812-2. Epub 2015 May 21.

50.

Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.

Duran R, Chapiro J, Schernthaner RE, Geschwind JF.

Br J Radiol. 2015 Aug;88(1052):20140564. doi: 10.1259/bjr.20140564. Epub 2015 May 15. Review.

Supplemental Content

Loading ...
Support Center